title: [A clinical analysis of 104 cases of acute pure and mixed organophosphate poisoning].
abstract: OBJECTIVE
  To study the difference of the clinical manifestations between single and mixed acute organophosphate (OP) poisoning.
  
  
  METHODS
  The clinical signs and symptoms, the activity of cholinesterase (ChE) in erythrocytes, plasma and whole blood, and the level of AST, CK, LDH and ALT were compared between a single OP poisoning group (Group S) and a mixed OP poisoning group (Group C).
  
  
  RESULTS
  Group S and Group C compare with: (1) Symptoms and signs on arrival at hospital: Group C was found to have more cases showing, nausea and vomiting than group S with obvious difference (P < 0.05). (2) The rates of other symptoms and signs were of no significant difference between the 2 groups. The activity of cholinesterase of the 2 groups on arrival at hospital: Whole blood ChE < 0.30: 16 cases and 14 cases; > 0.30 approximately : 24 cases and 19 cases; 0.50 approximately 0.70: 14 cases and 17 cases; erythrocyte ChE < 0.30: 18 cases and 14 cases; > 0.30 approximately : 22 cases and 21 cases; 0.50 approximately 0.70: 14 cases and 15 cases; plasma ChE < 0.30: 28 cases and 25 cases; > 0.30 approximately : 10 cases and 12 cases; 0.50 approximately 0.70: 16 cases and 13 cases; chi(2) = 0.852, 1.444, 0.509. There was no obvious difference (P > 0.05). (3) Positive rates of serum biochemical parameters between the 2 groups within 72 hours after arrival at hospital: Group S AST 24 cases, ALT 18 cases, CK 42 cases, LDH 22 cases, Tbil 21 cases; Group C AST 20 cases, ALT 11 cases, CK 32 cases, LDH 18 cases, Tbil 17 cases. There was also no obvious difference (P > 0.05). (4) Positive rate of ECG: between the 2 group on arrival at hospital Group S 24 cases, Group C 19 cases. No obvious difference was shown (P > 0.05). (5) Fatality rates between the 2 groups: Group S 7.41% (4/54), Group C 6.00% (3/50), chi(2) = 0.082, P > 0.05.
  
  
  CONCLUSIONS
  Acute mixed OP poisoning and single OP poisoning show no significant difference in clinical manifestations. The treatment measures for single OP poisoning also has good effect fo mixed OP poisoning.
authors.affiliation: The Third Clinical Hospital, Beijing University, Beijing 100083, China.
authors.forename: Jianyu
authors.initials: J
authors.lastname: Zhang
authors.forename: Jinyuan
authors.initials: J
authors.lastname: Zhao
authors.forename: Shaolian
authors.initials: S
authors.lastname: Sun
authors.forename: Haiyan
authors.initials: H
authors.lastname: Ma
authors.forename: Changlin
authors.initials: C
authors.lastname: Zhao
authors.forename: Zidian
authors.initials: Z
authors.lastname: Guo
authors.forename: Fengan
authors.initials: F
authors.lastname: Wang
mesh_terms: D000208:Acute Disease; D000293:Adolescent; D000328:Adult; D000410:Alanine Transaminase / Q000097:blood; D001219:Aspartate Aminotransferases / Q000097:blood; D002648:Child; D002802:Cholinesterases / Q000097:blood; D003402:Creatine Kinase / Q000097:blood; D005260:Female; D006801:Humans; D007306:Insecticides / Q000506:poisoning*; D007770:L-Lactate Dehydrogenase / Q000097:blood; D008297:Male; D008875:Middle Aged; D009325:Nausea / Q000209:etiology; D009946:Organothiophosphorus Compounds; D011041:Poisoning / Q000097:blood* / Q000150:complications / Q000401:mortality; D015996:Survival Rate; D014839:Vomiting / Q000209:etiology
chemical_list: D007306:Insecticides; D009946:Organothiophosphorus Compounds; D007770:L-Lactate Dehydrogenase; D001219:Aspartate Aminotransferases; D000410:Alanine Transaminase; D003402:Creatine Kinase; D002802:Cholinesterases